Regenix Drugs

Regenix Drugs Limited is a biopharmaceutical company headquartered in Chennai, India, specializing in the development, manufacturing, and marketing of biosimilar injections and small molecule formulations. Founded in 2007 by Dr. A. Ramamurthy, the company operates a state-of-the-art, WHO-GMP accredited facility dedicated to sterile fill-finish processes for vials, pre-filled syringes, and cartridges. Its core portfolio features high-demand biologics such as human insulin, insulin glargine, liraglutide, and enoxaparin sodium, alongside a diverse range of branded generics across therapeutic areas including cardiology, neurology, and gastroenterology. In addition to its domestic operations, Regenix serves as a CDMO partner and exports its pharmaceutical products to international markets in the CIS, Africa, and Asia.